BOXL vs UTI
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 23, 2026
BOXL
UTI
Investment Advisor Scores
UTI
AI Analyst Insights
Detailed Metrics Comparison
| Metric | BOXL | UTI | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 12.0482 | 32.3625 | BOXL |
| PEG Ratio | 0 | 2.16 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -16.0% | 7.2% | UTI |
| Earnings Growth | 337.6% | -78.9% | BOXL |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 38.3/100 | 47.3/100 | UTI |
| Profit Margin | -21.0% | 3.9% | UTI |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | EXTENDED | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
BOXL
MarkupPrice above SMA50, rising 50-day trend (60.5% over 20 days), RSI 56
UTI
MarkdownPrice below a falling SMA50 (slope -8.4%), weak momentum, RSI 26
Fundamentals Snapshot
| Metric | BOXL | UTI |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -0.1 | 30.4 |
| Trailing P/E | — | 39.5 |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.2% | 0.1% |
| Gross Margin | 0.3% | 0.6% |
| Operating Margin | 0.0% | 0.0% |
| EPS | -150.52 | 0.58 |
| Dividend Yield | — | — |